Celerion
621 Rose Street
Lincoln
Nebraska
68502
United States
Tel: 402-476-2811
Website: http://celerion.com/
Email: info@celerion.com
47 articles about Celerion
-
Celerion Achieves Milestone With CLIA Certification for Its Bioanalytical Laboratory, Expanding Capabilities in Clinical Trials and Diagnostic Testing
2/6/2024
Celerion , a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.
-
Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
11/10/2022
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announces the expansion of molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new modality therapies, such as cell and gene therapies.
-
Celerion Expands Early Phase Clinical Pharmacology Units
3/8/2022
Celerion, a clinical research organization to the biopharmaceutical industry, has announced completion of additions to its research capacity and services.
-
Celerion to Present at Upcoming Veeva Summit
10/9/2020
Celerion , a leading clinical research organization (CRO) provider to the biopharmaceutical industry, will deliver a key address on the final day of the V
-
Celerion Recognized as 2020 CRO Leadership Champion for Reliability and Receives CRO Leadership Award for Capabilities, Compatibility, Expertise, and Quality
6/16/2020
Celerion is proud to announce, for the fifth consecutive year, recognition of its early stage research development services across five categories in the 2020 CRO Leadership Awards sponsored by Life Science Leader and Industry Standard Research. Both small and large pharma respondents highlighted Celerion as a top performer in categories including Capabilities, Compatibility, Expertise, and Quality . Importantly,
-
Celerion Expands HRMS Metabolite Identification Capabilities for Full Service Metabolism Offering
6/5/2020
Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product. Celerion has created a compelling bioanalytical
-
Celerion Celebrates 50th Anniversary of First Clinical Trial
7/17/2019
Celerion is proud to celebrate the 50th anniversary of the first clinical trial conducted at our facilities in Lincoln, Nebraska.
-
Celerion Recognized as a Leading Contract Research Organization for the 4th Consecutive Year
3/27/2019
Celerion was recognized as a leader within the Small Pharmaceutical company group as well as a leader in the Overall group
-
Celerion Expands NASH Biomarkers Services With the Implementation of FibroScan®
10/31/2018
Celerion, a leader in early clinical research, is pleased to announce the implementation of FibroScan® to complement a suite of soluble biomarkers Celerion has validated to support nonalcoholic steatohepatitis (NASH) clinical studies.
-
Celerion Creates a Fully Automated, Early Development Clinical Trial Data Management Platform
1/17/2018
Celerion, the leader in early clinical development, is pleased to announce a new core capability for this growing market: the integration of ClinQuick, Celerion’s proprietary electronic data acquisition system, with TrialMaster, OmniComm’s electronic data capture solution, to provide a fully automated clinical trial data management platform.
-
Celerion Receives A 2017 CRO Leadership Award In Multiple Categories For Clinical Research Excellence
6/21/2017
-
Celerion Implements Biometric Fingerprint Technology And Marks Five-Year Anniversary With Verified Clinical Trials
3/14/2017
-
Celerion Appoints Dr. Marc Hoffman As Chief Medical Officer
2/22/2017
-
Celerion Announces Celexus As A Premier Safety Reporting Tool For Phase I Clinical Trials
11/17/2016
-
Celerion Named Best Translational Clinical Pharmacology Company 2016
10/5/2016
-
Celerion Recognized By Biopharmaceutical Clients As A Leader In Contract Research Quality Benchmarking Survey
5/31/2016
-
Assign Clinical Research Joins Celerion
1/11/2016
-
Celerion Expands Its Cell-Based Assays Capabilities In Global Bioanalytical Services
11/3/2014
-
Celerion Completes Recapitalization Through Investment By MTS Capital Health Partners
10/29/2014
-
Celerion Expands Ophthalmological Capabilities To Patient Populations In Collaboration With Queen’s University, Belfast.
9/30/2014